Literature DB >> 29323062

Role of p53 and Ki-67 immunomarkers in carcinoma of urinary bladder.

Brijesh Thakur1, Sanjeev Kishore1, Kanika Dutta1, Sanjay Kaushik1, Aparna Bhardwaj1.   

Abstract

BACKGROUND: Urothelial carcinoma is common urinary malignancy responsible for a significant proportion of cancer morbidity and mortality. We carried out the present study to demonstrate the clinicohistopathological features and to correlate the p53 and Ki-67 immunoexpression with grade and stage of bladder carcinomas.
MATERIALS AND METHODS: We investigated 110 cases of bladder tumor. Grading and staging were done according to the WHO-2004 and American Joint Committee on Cancer-TNM staging recommendations. Immunohistochemical staining for p53 and Ki-67 was performed in all the cases, categorized as high and low expression taking 20% positivity as cutoff value. Statistical analysis was done using McNemar's Chi-square test and Fisher's exact test.
RESULTS: There were 61 cases of high grade and 49 cases of low grade exhibiting urothelial carcinoma as the most common variant (97.3%). Muscle invasive carcinomas (pT2) noted in 29 cases whereas 23 and 58 cases revealed stage pTa and pT1, respectively. Evaluation of p53 and Ki-67 immunoexpression showed a significant association with histological grade and stage individually and also in combination (P < 0.05).
CONCLUSION: Our results corroborate with the opinion that combined use of p53 and Ki-67 immunomarkers may provide additional prognostic information along with histological grading and staging in bladder carcinomas.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29323062     DOI: 10.4103/IJPM.IJPM_246_17

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  The Apoptotic and Antiproliferative Effects of Capsaicin in the Developmental Stages of Oral Squamous Cell Carcinoma Induced in Hamsters.

Authors:  Amer Takkem; Safa Zakaraia; Ali Silan; Mohammad Alghazawi; Wisaam Sahyouni; Ahmad Al-Manadili
Journal:  Cureus       Date:  2022-06-19

2.  Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer.

Authors:  Rafał Stec; Szczepan Cierniak; Arkadiusz Lubas; Urszula Brzóskowska; Tomasz Syryło; Henryk Zieliński; Aleksandra Semeniuk-Wojtaś
Journal:  Pathol Oncol Res       Date:  2019-06-19       Impact factor: 3.201

Review 3.  The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know?

Authors:  Rafaela Malinaric; Guglielmo Mantica; Lorenzo Lo Monaco; Federico Mariano; Rosario Leonardi; Alchiede Simonato; André Van der Merwe; Carlo Terrone
Journal:  Int J Environ Res Public Health       Date:  2022-08-05       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.